Seres Therapeutics, Inc. (MCRB) — Dilution Risk Analysis

Current Snapshot

Seres Therapeutics, Inc. (MCRB) has a DilutionWatch score of 65/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
9,941,261 Source
Public Float
7,384,774 Source
Float as % of Outstanding
74.3%

Dilution Risk Score

Score: 65/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

Recent filing forms in the source payload: 3 1, 4 8, 8-K 1.

FormFiledAccession
3 2026-03-11 0001193125-26-102609
4 2026-03-11 0001193125-26-102617
4 2026-03-06 0001193125-26-096678
4 2026-03-06 0001193125-26-096692
4 2026-03-06 0001193125-26-096700
4 2026-03-06 0001193125-26-096711
8-K 2026-03-02 0001193125-26-085368
4 2026-02-18 0001193125-26-057153
4 2026-02-18 0001193125-26-057154
4 2026-02-18 0001193125-26-057157

Dilution Risk Drivers

DriverStored ValueSource
Cash runway 1 months Source
Three-year share count growth 53.82% Source

DilutionWatch Analysis

Risk Level
HIGH (Score: 65/10) Source
Cash Runway
1 months Source
Share Count Growth (3-Year)
53.82% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.